Prof. Jarząb: Testy wielogenowe są naprawdę pilne. To są narzędzia dostępne od 20 lat

Multigene tests allow us to determine which breast cancer patients require chemotherapy and which do not. Most healthcare systems reimburse these tests. Poland is one of the last developed countries where reimbursement is not available, says Prof. Michał Jarząb, head of the Breast Disease Diagnostics and Treatment Center at the National Institute of Imaging and Imaging in Gliwice.